Exagen (XGN) Gross Profit (2018 - 2026)

Exagen (XGN) has 9 years of Gross Profit data on file, last reported at $10.2 million in Q1 2026.

• Quarterly Gross Profit rose 11.86% year-over-year to $10.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $39.9 million (up 18.56% YoY) and the FY2025 annual result came in at $38.8 million, up 17.18% from the prior year.
• Gross Profit grew to $10.2 million in Q1 2026, from $9.2 million in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $10.4 million in Q2 2025 to a low of $1.5 million in Q2 2022.
• A 5-year average of $7.8 million and a median of $8.5 million in 2024 frame the typical range for Gross Profit.
• Annual changes were most pronounced in 2022 — Gross Profit slumped 79.13% — and 2023, when it jumped 443.26%.
• Tracing XGN's Gross Profit over 5 years: stood at $6.5 million in 2022, then climbed by 24.77% to $8.1 million in 2023, then gained by 4.08% to $8.5 million in 2024, then gained by 8.6% to $9.2 million in 2025, then grew by 10.85% to $10.2 million in 2026.
• The last three Gross Profit figures came in at $10.2 million (Q1 2026), $9.2 million (Q4 2025), and $10.1 million (Q3 2025), per Business Quant data.